The data for VAXINIA was excellent given they are early in Ph1 clinical trial but there's not enough released yet. Do you think PH will block JV or partnership deal from BP for IP early in their development stage as they are consider "cheap" value to him????
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)